1 Min Read
Feb 10 (Reuters) - Juno Therapeutics Inc :
* Vanguard Group Inc reports 5.52 percent passive stake in Juno Therapeutics Inc as of Dec. 31, 2016 - sec filing Source text (bit.ly/2kua0R2) Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.